Home > News > American Bio Medica and Nanogen Sign Supply Agreement
August 23rd, 2006
American Bio Medica and Nanogen Sign Supply Agreement
Abstract:
American Bio Medica Corporation (NASDAQ: ABMC), a global provider of immunoassay diagnostic test kits, and Nanogen, Inc. (NASDAQ: NGEN), a developer of advanced diagnostic products, announced today that they have entered into a supply agreement in which ABMC will sell its rapid drugs of abuse (DOA) tests to Nanogen.
Source:
businesswire
Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |